Research & Development

Can GC Therapeutics' TFome Platform Revolutionize Cell Therapy?
Research & Development Can GC Therapeutics' TFome Platform Revolutionize Cell Therapy?

GC Therapeutics (GCTx), a biotech company founded in 2019, has captured the spotlight with its pioneering approach to cell therapy. With a mission centered on advanced induced pluripotent stem cell (iPSC)-based medicines, GCTx is driven by its innovative TFome platform. Bolstered by a successful

Ascendis Trials Shake Up the Market for Achondroplasia Treatments
Research & Development Ascendis Trials Shake Up the Market for Achondroplasia Treatments

The competitive landscape of pharmaceutical treatments for achondroplasia, a common cause of dwarfism, is experiencing a seismic shift, thanks to the recent clinical trial results from Ascendis Pharma. BioMarin Pharmaceutical, a long-time player in this niche market, finds itself under significant

Can MinervaX and Wacker Biotech Transform GBS Prevention?
Research & Development Can MinervaX and Wacker Biotech Transform GBS Prevention?

In a significant move for maternal and neonatal healthcare, Danish biotech company MinervaX has teamed up with German CDMO Wacker Biotech to develop a groundbreaking prophylactic vaccine for Group B Streptococcus (GBS) infections. This partnership marks a pivotal step in addressing a critical unmet

Can Walgreens Revolutionize Clinical Trials with Its Retail Network?
Research & Development Can Walgreens Revolutionize Clinical Trials with Its Retail Network?

Walgreens, one of the nation’s largest retail pharmacy chains, is embarking on a monumental journey to transform its clinical trials business. This bold move, initiated in June 2022, leverages Walgreens' nationwide retail presence and extensive patient data to tap into the burgeoning pharmaceutical

iTeos’ Belrestotug and Jemperli Combo Shows Promise in Lung Cancer Trial
Research & Development iTeos’ Belrestotug and Jemperli Combo Shows Promise in Lung Cancer Trial

The world of cancer treatment is ever-evolving, and recent developments have brought a glimmer of hope for those battling non-small cell lung cancer (NSCLC). iTeos Therapeutics has unveiled promising results from a mid-stage clinical trial examining the efficacy of combining their drug,

Automated Cell Therapy Enhanced by Cellares and Sony Collaboration
Research & Development Automated Cell Therapy Enhanced by Cellares and Sony Collaboration

The landscape of cell therapy manufacturing is on the brink of transformation as Cellares, an Integrated Development and Manufacturing Organization (IDMO), partners with Sony Corporation to integrate advanced cell analysis and sorting technologies into an already sophisticated manufacturing

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later